Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

BAP1 loss defines a new class of renal cell carcinoma.

Nature genetics | Jul 28, 2012

http://www.ncbi.nlm.nih.gov/pubmed/22683710

The molecular pathogenesis of renal cell carcinoma (RCC) is poorly understood. Whole-genome and exome sequencing followed by innovative tumorgraft analyses (to accurately determine mutant allele ratios) identified several putative two-hit tumor suppressor genes, including BAP1. The BAP1 protein, a nuclear deubiquitinase, is inactivated in 15% of clear cell RCCs. BAP1 cofractionates with and binds to HCF-1 in tumorgrafts. Mutations disrupting the HCF-1 binding motif impair BAP1-mediated suppression of cell proliferation but not deubiquitination of monoubiquitinated histone 2A lysine 119 (H2AK119ub1). BAP1 loss sensitizes RCC cells in vitro to genotoxic stress. Notably, mutations in BAP1 and PBRM1 anticorrelate in tumors (P = 3 × 10(-5)), [corrected] and combined loss of BAP1 and PBRM1 in a few RCCs was associated with rhabdoid features (q = 0.0007). BAP1 and PBRM1 regulate seemingly different gene expression programs, and BAP1 loss was associated with high tumor grade (q = 0.0005). Our results establish the foundation for an integrated pathological and molecular genetic classification of RCC, paving the way for subtype-specific treatments exploiting genetic vulnerabilities.

Pubmed ID: 22683710 RIS Download

Mesh terms: Aged | Carcinoma, Renal Cell | Cell Growth Processes | Cells, Cultured | Exome | Female | Gene Expression | Host Cell Factor C1 | Humans | Kidney Neoplasms | Male | Middle Aged | Mutation | Nuclear Proteins | Protein Interaction Domains and Motifs | Transcription Factors | Tumor Suppressor Proteins | Ubiquitin Thiolesterase

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: 1P30CA142543
  • Agency: NCI NIH HHS, Id: P30 CA142543
  • Agency: NCI NIH HHS, Id: R01 CA129387
  • Agency: NCI NIH HHS, Id: R01 CA129387
  • Agency: NIGMS NIH HHS, Id: R01 GM094575

Comparative Toxicogenomics Database (Data, Disease Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.